hotspot -WSS

hotspot

author：leisure time 2025-09-27 12:57:36 - browse：48

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Readout Newsletter: Bristol, Sangamo, Gilead, and more

WSS

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

HHS secretary Becerra pressed on Change HealthCare cyberattack

Steward Health Care Massachusetts hospitals face fiscal disaster

Why scientists need input from humanists on sensitive research

World's first CRISPR

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

hotspot

hotspot

entertainment

Cancer drug shortages should be causing more outrage

HHS secretary Becerra pressed on Change HealthCare cyberattack

Medical records are filled with copy

RaDonda Vaught links Vanderbilt hospital issues to patient death

Bright Health sells Medicare Advantage business to Molina

Readout Newsletter: CAR

Malaria cases in Florida and Texas: Here’s what you need to know

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Anthos stroke drug appears safer than common blood thinner

explore

NYU radiologists take on the challenge of expensive MRI machines

Medicare coverage of Wegovy, once blocked, now looks possible

FDA's Woodcock to retire early next year

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

WuXi out of biotech trade group, U.S. and China relations to blame

HHS secretary Becerra pressed on Change HealthCare cyberattack

focus

entertainment

explore

Wikipedia